GB0304672D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0304672D0
GB0304672D0 GB0304672A GB0304672A GB0304672D0 GB 0304672 D0 GB0304672 D0 GB 0304672D0 GB 0304672 A GB0304672 A GB 0304672A GB 0304672 A GB0304672 A GB 0304672A GB 0304672 D0 GB0304672 D0 GB 0304672D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0304672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0304672A priority Critical patent/GB0304672D0/en
Publication of GB0304672D0 publication Critical patent/GB0304672D0/en
Priority to US10/526,151 priority patent/US20060104943A1/en
Priority to EP03791033A priority patent/EP1534329A2/en
Priority to EP03791019A priority patent/EP1532172A2/en
Priority to CA002496409A priority patent/CA2496409A1/en
Priority to AU2003259374A priority patent/AU2003259374A1/en
Priority to ARP030103127A priority patent/AR041086A1/en
Priority to EP03791038A priority patent/EP1534323A2/en
Priority to PCT/GB2003/003703 priority patent/WO2004019974A2/en
Priority to CA002496948A priority patent/CA2496948A1/en
Priority to AU2003260748A priority patent/AU2003260748A1/en
Priority to JP2004532301A priority patent/JP2006501249A/en
Priority to JP2004532284A priority patent/JP2006503017A/en
Priority to PCT/GB2003/003721 priority patent/WO2004019979A2/en
Priority to JP2004532296A priority patent/JP2006503018A/en
Priority to TW092123745A priority patent/TW200407162A/en
Priority to PCT/GB2003/003729 priority patent/WO2004019975A2/en
Priority to US10/526,060 priority patent/US20060147417A1/en
Priority to CA002496607A priority patent/CA2496607A1/en
Priority to AU2003259358A priority patent/AU2003259358A1/en
Ceased legal-status Critical Current

Links

GB0304672A 2002-08-30 2003-02-28 Vaccines Ceased GB0304672D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0304672A GB0304672D0 (en) 2003-02-28 2003-02-28 Vaccines
AU2003259358A AU2003259358A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
PCT/GB2003/003703 WO2004019974A2 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
AU2003260748A AU2003260748A1 (en) 2002-08-30 2003-08-28 Il-14 vaccine for the treatment of asthma and atopic disorders
EP03791019A EP1532172A2 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and itstherapeutic use
CA002496409A CA2496409A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
AU2003259374A AU2003259374A1 (en) 2002-08-30 2003-08-28 Vaccine comprising il-13 and an adjuvant
ARP030103127A AR041086A1 (en) 2002-08-30 2003-08-28 VACCINE
EP03791038A EP1534323A2 (en) 2002-08-30 2003-08-28 Il-14 vaccine for the treatment of asthma and atopic disorders
US10/526,151 US20060104943A1 (en) 2002-08-30 2003-08-28 Vaccine comprising il-13 and an adjuvant
CA002496948A CA2496948A1 (en) 2002-08-30 2003-08-28 Il-14 vaccine for the treatment of asthma and atopic disorders
EP03791033A EP1534329A2 (en) 2002-08-30 2003-08-28 Vaccine comprising il-13 and an adjuvant
JP2004532301A JP2006501249A (en) 2002-08-30 2003-08-28 vaccine
JP2004532284A JP2006503017A (en) 2002-08-30 2003-08-28 Immunogenic composition comprising IL-13 element and T cell epitope and therapeutic use thereof
PCT/GB2003/003721 WO2004019979A2 (en) 2002-08-30 2003-08-28 Vaccine comprising il-13 and an adjuvant
JP2004532296A JP2006503018A (en) 2002-08-30 2003-08-28 vaccine
TW092123745A TW200407162A (en) 2002-08-30 2003-08-28 Vaccine
PCT/GB2003/003729 WO2004019975A2 (en) 2002-08-30 2003-08-28 Il-14 vaccine for the treatment of asthma and atopic disorders
US10/526,060 US20060147417A1 (en) 2002-08-30 2003-08-28 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
CA002496607A CA2496607A1 (en) 2002-08-30 2003-08-28 Vaccine comprising il-13 and an adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0304672A GB0304672D0 (en) 2003-02-28 2003-02-28 Vaccines

Publications (1)

Publication Number Publication Date
GB0304672D0 true GB0304672D0 (en) 2003-04-02

Family

ID=9953897

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0304672A Ceased GB0304672D0 (en) 2002-08-30 2003-02-28 Vaccines

Country Status (1)

Country Link
GB (1) GB0304672D0 (en)

Similar Documents

Publication Publication Date Title
GB0226722D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225788D0 (en) Vaccine
AU2003285320A8 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0323840D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0305794D0 (en) Vaccine
GB0330079D0 (en) Vaccine
GB0321614D0 (en) Vaccines
GB0305793D0 (en) Vaccine
GB0304634D0 (en) Vaccines
GB0212036D0 (en) Vaccines
GB0206595D0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0304635D0 (en) Vaccines
GB0300397D0 (en) Vaccines
GB0300914D0 (en) Vaccines
GB0304672D0 (en) Vaccines
GB0313737D0 (en) Improved vaccines
GB0223355D0 (en) Vaccine
GB0305028D0 (en) Vaccine
GB0329827D0 (en) Vaccine
GB0327885D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)